Related Experiment Video
Updated: Apr 8, 2026

A Rat Carotid Balloon Injury Model to Test Anti-vascular Remodeling Therapeutics
Published on: September 19, 2016
Soluble RAGEs - Prospects for treating & tracking metabolic and inflammatory disease
1Diabetes Research Program, Division of Endocrinology, Department of Medicine, New York University Langone Medical Center, 550 First Avenue, New York, NY 10016, United States.
Abstract:
Emerging evidence links the receptor for advanced glycation endproducts (RAGE) to the pathogenesis of tissue damage in chronic metabolic and inflammatory diseases. In human subjects, multiple reports suggest that in the plasma/serum, circulating levels of distinct forms of soluble RAGEs may be biomarkers of the presence or absence, and the extent of chronic disease. These considerations prompt us to consider in this review, what are soluble RAGEs; how are they formed; what might be their natural functions; and may they serve as biomarkers of inflammatory and metabolic disease activity? In this brief review, we seek to address what is known and suggest new areas for scientific investigation to uncover the biology of soluble RAGEs.
Insights
Soluble forms of the receptor for advanced glycation endproducts (RAGE) are linked to chronic diseases. These soluble RAGEs may serve as biomarkers for disease activity in metabolic and inflammatory conditions.
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- The receptor for advanced glycation endproducts (RAGE) is implicated in tissue damage in chronic metabolic and inflammatory diseases.
- Circulating levels of soluble RAGEs in human plasma/serum are reported as potential biomarkers.
Purpose of the Study:
- To review the current understanding of soluble RAGEs.
- To explore their formation, natural functions, and potential as biomarkers for disease activity.
- To identify areas for future scientific investigation.
Main Methods:
- Literature review of existing evidence on RAGE and soluble RAGEs.
- Analysis of reports on RAGE in human subjects and disease pathogenesis.
Main Results:
- Emerging evidence connects RAGE to the pathogenesis of tissue damage in chronic diseases.
- Soluble RAGE forms in circulation may indicate the presence and extent of chronic disease.
Conclusions:
- Soluble RAGEs are potential biomarkers for inflammatory and metabolic disease activity.
- Further research is needed to fully elucidate the biology of soluble RAGEs and their clinical utility.
More Related Videos
06:05Advanced Glycation End-Products Sensitize Human Sensory-Like Neuron Cells to Capsaicin-Induced Calcium Influx
Published on: May 2, 2025
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
Related Concept Videos
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Proteoglycans
Spare Receptors